Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7248Neoplasms 4547Prostatic Neoplasms 3494Colorectal Neoplasms 2941Carcinoma, Non-Small-Cell Lung 2832Lung Neoplasms 2548Leukemia, Myeloid, Acute 1983Pancreatic Neoplasms 1875Multiple Myeloma 1812Carcinoma, Hepatocellular 1735Neoplasm Metastasis 1587Stomach Neoplasms 1502Lymphoma 1457Head and Neck Neoplasms 1437Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Brain Neoplasms 1374Melanoma 1349Ovarian Neoplasms 1347Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1140Uterine Cervical Neoplasms 1098Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 938Lymphoma, Large B-Cell, Diffuse 933Squamous Cell Carcinoma of Head and Neck 921

Interventions

Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interventional × Laparoscopic Surgery × Clear all
NCT07458295 2026-03-17

The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology

Beijing Tiantan Hospital

Phase NA Recruiting
110 enrolled

Laparoscopic Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡